Association of echocardiographic atrial size and atrial fibrosis in a sequential model of congestive heart failure and atrial fibrillation

Cardiovascular Pathology

Volumn 17, Issue 5, 2008, Pages 318-324

  Knackstedt, Christian ^a   Gramley, Felix ^a   Schimpf, Thomas ^a   Mischke, Karl ^a   Zarse, Markus ^a   Plisiene, Jurgita ^a   Schmid, Michael ^a   Lorenzen, Johann ^a   Frechen, Dirk ^a   Neef, Philipp ^a   Hanrath, Peter ^a   Kelm, Malte ^a   Schauerte, Patrick ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Atrial fibrillation; Atrial size; Congestive heart failure; Echocardiography; Fibrosis

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DOG; ECHOCARDIOGRAPHY; HEART ATRIUM FIBRILLATION; HEART EJECTION FRACTION; HEART LEFT ATRIUM; HEART MUSCLE FIBROSIS; HEMODYNAMICS; HISTOLOGY; NONHUMAN; PRIORITY JOURNAL; SINUS RHYTHM;

ANIMALS; ATRIAL FIBRILLATION; CARDIAC PACING, ARTIFICIAL; DISEASE MODELS, ANIMAL; DOGS; ECHOCARDIOGRAPHY; FIBROSIS; HEART ATRIA; HEART FAILURE; STROKE VOLUME;

EID: 50549094395     PISSN: 10548807     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carpath.2007.12.003     Document Type: Article

References (26)

1. Feinberg W.M., Blackshear J.L., Laupacis A., Kronmal R., and Hart R.G. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med 155 (1995) 469-473
2. Crijns H.J., Van Gelder I.C., Van Gilst W.H., Hillege H., Gosselink, and Lie K.I. Serial antiarrhythmic drug treatment to maintain sinus rhythm after electrical cardioversion for chronic atrial fibrillation or atrial flutter. Am J Cardiol 68 (1991) 335-341
3. Cuddy T.E. Chronic and paroxysmal atrial fibrillation: course, prognosis, and stroke risk. J Thromb Thrombolysis 7 (1999) 7-11
4. Henry W.L., Morganroth J., Pearlman, Clark C.E., Redwood D.R., Itscoitz S.B., and Epstein S.E. Relation between echocardiographically determined left atrial size and atrial fibrillation. Circulation 53 (1976) 273-279
5. Shi Y., Li D., Tardif J.C., and Nattel S. Enalapril effects on atrial remodeling and atrial fibrillation in experimental congestive heart failure. Cardiovasc Res 54 (2002) 456-461
6. Neuberger H.R., Schotten U., Blaauw Y., Vollmann D., Eijsbouts S., van Hunnik A., and Allessie M. Chronic atrial dilation, electrical remodeling, and atrial fibrillation in the goat. J Am Coll Cardiol 47 (2006) 644-653
7. Li D., Fareh S., Leung T.K., and Nattel S. Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort. Circulation 100 (1999) 87-95
8. Shinagawa K., Shi Y.F., Tardif J.C., Leung T.K., and Nattel S. Dynamic nature of atrial fibrillation substrate during development and reversal of heart failure in dogs. Circulation 105 (2002) 2672-2678
9. Sanfilippo A.J., Abascal V.M., Sheehan M., Oertel L.B., Harrigan P., Hughes R.A., and Weyman A.E. Atrial enlargement as a consequence of atrial fibrillation. A prospective echocardiographic study. Circulation 82 (1990) 792-797
10. Sahn D., DeMaria A., Kisslo J., and Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58 (1978) 1072-1083
11. Schiller N.B., Shah P.M., Crawford M., DeMaria A., Devereux R., Feigenbaum H., Gutgesell H., Reichek N., Sahn D., and Schnittger I. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 2 (1989) 358-367
12. Fraser H.R., and Turner R.W. Auricular fibrillation; with special reference to rheumatic heart disease. Br Med J 4953 (1955) 1414-1418
13. Psaty B.M., Manolio T.A., Kuller L.H., Kronmal R.A., Cushman M., Fried L.P., White R., Furberg C.D., and Rautaharju P.M. Incidence of and risk factors for atrial fibrillation in older adults. Circulation 96 (1997) 2455-2461
14. Schotten U., Neuberger H.R., and Allessie M.A. The role of atrial dilatation in the domestication of atrial fibrillation. Prog Biophys Mol Biol 82 (2003) 151-162
15. Boldt A., Wetzel U., Lauschke J., Weigl J., Gummert J., Hindricks G., Kottkamp H., and Dhein S. Fibrosis in left atrial tissue of patients with atrial fibrillation with and without underlying mitral valve disease. Heart 90 (2004) 400-405
16. Goette A., Staack T., Rocken C., Arndt M., Geller J.C., Huth C., Ansorge S., Klein H.U., and Lendeckel U. Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation. J Am Coll Cardiol 35 (2000) 1669-1677
17. Li D., Shinagawa K., Pang L., Leung T.K., Cardin S., Wang Z., and Nattel S. Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure. Circulation 104 (2001) 2608-2614
18. Cha T.J., Ehrlich J.R., Zhang L., Shi Y.F., Tardif J.C., Leung T.K., and Nattel S. Dissociation between ionic remodeling and ability to sustain atrial fibrillation during recovery from experimental congestive heart failure. Circulation 109 (2004) 412-418
19. Wyse D.G., Waldo A.L., DiMarco J.P., Domanski M.J., Rosenberg Y., Schron E.B., Kellen J.C., Greene H.L., Mickel M.C., Dalquist J.E., and Corley S.D. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 347 (2002) 1825-1833
20. Van Gelder I.C., Hagens V.E., Bosker H.A., Kingma J.H., Kamp O., Kingma T., Said S.A., Darmanata J.I., Timmermans A.J., Tijssen J.G., and Crijns H.J. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 347 (2002) 1834-1840
21. Pedersen O.D., Bagger H., Keller N., Marchant B., Kober L., and Torp-Pedersen C. Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: a Danish Investigations of Arrhythmia and Mortality on Dofetilide (DIAMOND) substudy. Circulation 104 (2001) 292-296
22. Pozzoli M., Cioffi G., Traversi E., Pinna G.D., Cobelli F., and Tavazzi L. Predictors of primary atrial fibrillation and concomitant clinical and hemodynamic changes in patients with chronic heart failure: a prospective study in 344 patients with baseline sinus rhythm. J Am Coll Cardiol 32 (1998) 197-204
23. Hanna N., Cardin S., Leung T.K., and Nattel S. Differences in atrial versus ventricular remodeling in dogs with ventricular tachypacing-induced congestive heart failure. Cardiovasc Res 63 (2004) 236-244
24. Gramley F., Lorenzen J., Plisiene J., Rakauskas M., Benetis R., Schmid M., Autschbach R., Knackstedt C., Thomas S., Karl M., Gressner A., Hanrath P., Kelm M., and Schauerte P. Decreased plasminogen activator inhibitor and tissue metalloproteinase inhibitor expression may promote increased metalloproteinase activity with increasing duration of human atrial fibrillation. J Cardiovasc Electrophysiol 18 (2007) 1076-1082
25. Verheule S., Wilson E., Everett T., Shanbhag S., Golden C., and Olgin J. Alterations in atrial electrophysiology and tissue structure in a canine model of chronic atrial dilatation due to mitral regurgitation. Circulation 107 (2003) 2615-2622
26. Khankirawatana B., Khankirawatana S., and Porter T. How should left atrial size be reported? Comparative assessment with use of multiple echocardiographic methods. Am Heart J 147 (2004) 369-374